DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTCBB:CONX), a worldwide developer and marketer of diagnostic test kits, has announced promising results from a preliminary clinical trial involving its AtherOxTM test kit. The study was sponsored by Corgenix and Medical & Biological Laboratories, Ltd.
